{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:36:14Z","timestamp":1789994174572,"version":"4.0.1"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.biopha.2017.11.127","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T04:10:56Z","timestamp":1512533456000},"page":"1478-1490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Recent advances in delivery of antifungal agents for therapeutic management of candidiasis"],"prefix":"10.1016","volume":"96","author":[{"given":"Bhakti","family":"Sawant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassum","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.diagmicrobio.2007.06.008","article-title":"Presentation of the PATH Alliance\u00ae registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections","volume":"59","author":"Horn","year":"2007","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408410903241444","article-title":"Epidemiology of invasive mycoses in North America","volume":"36","author":"Pfaller","year":"2010","journal-title":"Crit. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/432060","article-title":"Emerging fungal diseases","volume":"41","author":"Nucci","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1086\/504490","article-title":"Invasive fungal pathogens: current epidemiological trends","volume":"43","author":"Pfaller","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.127_bib0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/viru.22913","article-title":"Candida albicans pathogenicity mechanisms","volume":"4","author":"Mayer","year":"2013","journal-title":"Virulence"},{"issue":"5","key":"10.1016\/j.biopha.2017.11.127_bib0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management candidiasis: 2009 update by the infectious diseases society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.127_bib0040","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.semperi.2012.06.003","article-title":"Treatment and prophylaxis of invasive candidiasis","volume":"36","author":"Tripathi","year":"2012","journal-title":"Semin. Perinatol."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.127_bib0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.fgb.2010.08.010","article-title":"Activation of the heat shock transcription factor Hsf1 is essential for the full virulence of the fungal pathogen Candida albicans","volume":"48","author":"Nicholls","year":"2011","journal-title":"Fungal Genet. Biol."},{"issue":"12","key":"10.1016\/j.biopha.2017.11.127_bib0050","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nrg948","article-title":"Candida albicans: a molecular revolution built on lessons from budding yeast","volume":"3","author":"Berman","year":"2002","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biopha.2017.11.127_bib0055","series-title":"Candida and Candidiasis: A Review and Bibliography","author":"Odds","year":"1988"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0060","doi-asserted-by":"crossref","first-page":"e1002585","DOI":"10.1371\/journal.ppat.1002585","article-title":"Fungal biofilms","volume":"8","author":"Fanning","year":"2012","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.127_bib0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrmicro2475","article-title":"Genetic control of Candida albicans biofilm development","volume":"9","author":"Finkel","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-6-21","article-title":"Epidemiological trends in nosocomial candidemia in intensive care","volume":"6","author":"Bassetti","year":"2006","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0075","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jhin.2001.1151","article-title":"Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance","volume":"50","author":"Krcmery","year":"2002","journal-title":"J. Hosp. Infect."},{"issue":"12","key":"10.1016\/j.biopha.2017.11.127_bib0080","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry","volume":"48","author":"Horn","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2017.11.127_bib0085","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"September","key":"10.1016\/j.biopha.2017.11.127_bib0090","first-page":"069","article-title":"Candida species diversity and antifungal susceptibility patterns in oral samples of HIV\/AIDS patients in Baja California, Mexico","author":"Clark-Ord\u00f3\u00f1ez","year":"2016","journal-title":"Med. Mycol."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0095","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1034\/j.1600-0714.2001.300406.x","article-title":"Risk factors associated with oral lesions in HIV\u2010infected heterosexual people and intravenous drug users in Thailand","volume":"30","author":"Nittayananta","year":"2001","journal-title":"J. Oral Pathol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-8-135","article-title":"Species distribution and in-vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis","volume":"8","author":"Hamza","year":"2008","journal-title":"BMC Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1034\/j.1600-0714.2002.310102.x","article-title":"Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV\u2010infected patients","volume":"31","author":"Campo","year":"2002","journal-title":"J. Oral Pathol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1601-0825.1995.tb00156.x","article-title":"Clinical, microbiological and ultrastructural features of angular cheilitis lesions in Southern Chinese","volume":"1","author":"Dias","year":"1995","journal-title":"Oral Dis."},{"key":"10.1016\/j.biopha.2017.11.127_bib0115","series-title":"Clinical Oral Microbiology","author":"MacFarlane","year":"2014"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/10454411990100010501","article-title":"Denture plaque and adherence of Candida albicans to denture-base materials in-vivo and in-vitro","volume":"10","author":"Radford","year":"1999","journal-title":"Crit. Rev. Oral Biol. Med."},{"issue":"15","key":"10.1016\/j.biopha.2017.11.127_bib0125","first-page":"114","article-title":"Denture stomatitis: a brief review","volume":"1","author":"Karthikeyan","year":"2016","journal-title":"IOSR-JDMS"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00016357009033133","article-title":"Denture stomatitis I. The etiology in relation to trauma and infection","volume":"28","author":"Budtz-J\u00f6rgensen","year":"1970","journal-title":"Acta Odontol. Scand."},{"key":"10.1016\/j.biopha.2017.11.127_bib0135","doi-asserted-by":"crossref","DOI":"10.3402\/jom.v3i0.5771","article-title":"Pathogenesis and treatment of oral candidiasis","volume":"3","author":"Williams","year":"2011","journal-title":"J. Oral Microbiol."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.127_bib0140","first-page":"36","article-title":"Oral candidiasis and the therapeutic use of antifungal agents in dentistry","volume":"50","author":"McCullough","year":"2005","journal-title":"Aust. Dent. J."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.127_bib0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1601-0825.2000.tb00106.x","article-title":"Pathology and clinical correlates in oral candidiasis and its variants: a review","volume":"6","author":"Reichart","year":"2000","journal-title":"Oral Dis."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1590\/S1678-77572008000400004","article-title":"Incidence and anatomic localization of oral candidiasis in patients with AIDS hospitalized in a public hospital in Belo Horizonte, MG, Brazil","volume":"16","author":"Gableri","year":"2008","journal-title":"J. Appl. Oral Sci."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.127_bib0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1601-0825.2006.01357.x","article-title":"Antimicrobials as a contributory factor in oral candidiasis\u2013a brief overview","volume":"14","author":"Soysa","year":"2008","journal-title":"Oral Dis."},{"issue":"s2","key":"10.1016\/j.biopha.2017.11.127_bib0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1034\/j.1601-0825.2002.00017.x","article-title":"Oral fungal and bacterial infections in HIV\u2010infected individuals: an overview in Africa","volume":"8","author":"Hodgson","year":"2002","journal-title":"Oral Dis."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0165","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0030-4220(83)90349-3","article-title":"Clinical, therapeutic, and pathogenic aspects of chronic oral multifocal candidiasis","volume":"56","author":"Holmstrup","year":"1983","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0170","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/154411130301400403","article-title":"Chronic hyperplastic candidiasis\/candidiasis (candidal leukoplakia)","volume":"14","author":"Sitheeque","year":"2003","journal-title":"Crit. Rev. Oral Biol. Med."},{"issue":"9","key":"10.1016\/j.biopha.2017.11.127_bib0175","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa033114","article-title":"Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis","volume":"351","author":"Sobel","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.127_bib0180","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/CMR.00076-09","article-title":"Candida infections of the genitourinary tract","volume":"23","author":"Achkar","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0185","doi-asserted-by":"crossref","first-page":"e1003965","DOI":"10.1371\/journal.ppat.1003965","article-title":"Candida vaginitis: when opportunism knocks, the host responds","volume":"10","author":"Peters","year":"2014","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.127_bib0190","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/CMR.9.3.335","article-title":"Immunopathogenesis of recurrent vulvovaginal candidiasis","volume":"9","author":"Fidel","year":"1996","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0195","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/clinids\/14.Supplement_1.S148","article-title":"Pathogenesis and treatment of recurrent vulvovaginal candidiasis","volume":"14","author":"Sobel","year":"1992","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0200","article-title":"Vulvovaginal candidiasis","volume":"82","author":"White","year":"2006","journal-title":"Sex. Transm. Infect."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.127_bib0205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/sti.75.6.417","article-title":"Microscopic features of vaginal candidiasis and their relation to symptomatology","volume":"75","author":"Sonnex","year":"1999","journal-title":"Sex. Transm. Infect."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.127_bib0210","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.idc.2006.07.004","article-title":"Invasive candidiasis","volume":"20","author":"Pappas","year":"2006","journal-title":"Infect. Dis. Clin. N. Am."},{"issue":"15","key":"10.1016\/j.biopha.2017.11.127_bib0215","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.127_bib0220","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.127_bib0225","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","article-title":"Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study","volume":"33","author":"Blumberg","year":"2001","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2017.11.127_bib0230","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s15010-002-2131-0","article-title":"In-vivo pathogenicity of eight medically relevant Candida species in an animal model","volume":"30","author":"Arendrup","year":"2002","journal-title":"Infection"},{"issue":"6","key":"10.1016\/j.biopha.2017.11.127_bib0235","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","article-title":"Candida colonization and subsequent infections in critically ill surgical patients","volume":"220","author":"Pittet","year":"1994","journal-title":"Ann. Surg."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0240","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JCM.40.4.1244-1248.2002","article-title":"Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources","volume":"40","author":"Shin","year":"2002","journal-title":"J. Clin. Microbiol."},{"issue":"9","key":"10.1016\/j.biopha.2017.11.127_bib0245","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1128\/AAC.48.9.3291-3297.2004","article-title":"Penetration of Candida biofilms by antifungal agents","volume":"48","author":"Al-Fattani","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0250","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2591.2008.01540.x","article-title":"The properties and applications of chlorhexidine in endodontics","volume":"42","author":"Mohammadi","year":"2009","journal-title":"Int. Endod. J."},{"issue":"July (7)","key":"10.1016\/j.biopha.2017.11.127_bib0255","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1034\/j.1600-051X.2003.00307.x","article-title":"Effects of dynamic fluid activity from an electric toothbrush on in-vitro oral biofilms","volume":"30","author":"Hope","year":"2003","journal-title":"J. Clin. Periodontol."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0260","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/13693780500138971","article-title":"An update on antifungal targets and mechanisms of resistance in Candida albicans","volume":"43","author":"Akins","year":"2005","journal-title":"Med. Mycol."},{"issue":"9312","key":"10.1016\/j.biopha.2017.11.127_bib0265","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(02)08162-X","article-title":"Antifungal drug resistance of pathogenic fungi","volume":"359","author":"Kontoyiannis","year":"2002","journal-title":"Lancet"},{"issue":"October (4)","key":"10.1016\/j.biopha.2017.11.127_bib0270","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1128\/CMR.12.4.501","article-title":"Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance","volume":"12","author":"Ghannoum","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0275","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1128\/AAC.47.4.1179-1186.2003","article-title":"In-vivo pharmacodynamics of antifungal drugs in treatment of candidiasis","volume":"47","author":"Andes","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.127_bib0280","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/AAC.48.2.568-574.2004","article-title":"Three-dimensional models of wild-type and mutated forms of cytochrome P450 14\u03b1-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding","volume":"48","author":"Xiao","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0285","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/106002809502900102","article-title":"Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis","volume":"29","author":"Force","year":"1995","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0290","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10266-009-0118-3","article-title":"Antifungal drug resistance of oral fungi","volume":"98","author":"Niimi","year":"2010","journal-title":"Odontology"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0757.2008.00291.x","article-title":"Oral mucosal fungal infections","volume":"49","author":"Samaranayake","year":"2009","journal-title":"Periodontol. 2000"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0300","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1098-0997(1996)4:4<247::AID-IDOG9>3.0.CO;2-W","article-title":"New treatments for vulvovaginal candidiasis","volume":"4","author":"Faro","year":"1996","journal-title":"Infect. Dis. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0305","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0190-9622(08)81838-5","article-title":"Risk\/benefit ratio of modern antifungal therapy: focus on hepatic reactions","volume":"29","author":"Hay","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.biopha.2017.11.127_bib0310","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1128\/AAC.00057-14","article-title":"Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry","volume":"58","author":"Maiolo","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0315","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0002-9378(95)91490-0","article-title":"Fluconazole vaginitis study group. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis","volume":"172","author":"Sobel","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.127_bib0320","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1471-0528.1989.tb01667.x","article-title":"A comparison of single\u2010dose oral fluconazole with 3\u2010day intravaginal clotrimazole in the treatment of vaginal candidiasis","volume":"96","author":"Andersen","year":"1989","journal-title":"BJOG: Int. J. Gynaecol. Obstet."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0325","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0028-2243(88)90071-8","article-title":"A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial","volume":"29","author":"Kutzer","year":"1988","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2017.11.127_bib0330","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/00016349009013305","article-title":"Single\u2010dose oral fluconazole versus single\u2010dose topical miconazole for the treatment of acute vulvovaginal candidiasis","volume":"69","author":"Heusden","year":"1990","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.biopha.2017.11.127_bib0335","first-page":"29","article-title":"Fluconazole versus econazole in treating vaginal candidiasis","volume":"37","author":"Westr\u00f6m","year":"1992","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.127_bib0340","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/JCM.00131-07","article-title":"Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia","volume":"45","author":"Tumbarello","year":"2007","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0345","first-page":"38","article-title":"Novel drug delivery approaches for the management of oral candidiasis","volume":"8","author":"Rohilla","year":"2016","journal-title":"Pharm. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.127_bib0350","first-page":"970","article-title":"Novel drug delivery systems: an overview","volume":"4","author":"Bhagwat","year":"2013","journal-title":"Int. J. Pharm. Sci. Res."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0355","first-page":"77","article-title":"Novel vesicular carriers for topical drug delivery and their application\u2019s","volume":"21","author":"Shilakari","year":"2013","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.biopha.2017.11.127_bib0360","series-title":"Liposome Dermatics","first-page":"20","article-title":"Basic principles of liposomes for drug use","author":"Martin","year":"1992"},{"key":"10.1016\/j.biopha.2017.11.127_bib0365","series-title":"Colloidal Drug Delivery Systems","author":"Kreuter","year":"1994"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0370","first-page":"6","article-title":"Novel drug delivery systems for antifungal therapyInt","volume":"2","author":"Khatry","year":"2010","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"issue":"October (1)","key":"10.1016\/j.biopha.2017.11.127_bib0380","first-page":"20","article-title":"Nano to micro delivery systems: targeting angiogenesis in brain tumors","volume":"2","author":"Gilert","year":"2010","journal-title":"Vasc. Cell"},{"issue":"August (2)","key":"10.1016\/j.biopha.2017.11.127_bib0385","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.supflu.2010.05.002","article-title":"Biological activities of the rice bran extract and physical characteristics of its entrapment in niosomes by supercritical carbon dioxide fluid","volume":"54","author":"Manosroi","year":"2010","journal-title":"J. Supercrit. Fluids"},{"issue":"2","key":"10.1016\/j.biopha.2017.11.127_bib0390","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jac\/dki454","article-title":"Enhanced efficacy of pH-sensitive nystatin liposomes against Cryptococcus neoformans in murine model","volume":"57","author":"Nasti","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.127_bib0395","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003495-200969030-00010","article-title":"Liposomal amphotericin B","volume":"69","author":"Moen","year":"2009","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.biopha.2017.11.127_bib0400","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/10611860903079454","article-title":"Niosomes in sustained and targeted drug delivery: some recent advances","volume":"17","author":"Azeem","year":"2009","journal-title":"J. Drug Target"},{"issue":"12","key":"10.1016\/j.biopha.2017.11.127_bib0405","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3109\/03639045.2011.587431","article-title":"Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin","volume":"37","author":"El-Ridy","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0410","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/2230-973X.107002","article-title":"Formulation and evaluation of Ketoconazole niosomal gel drug delivery system","volume":"2","author":"Shirsand","year":"2012","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.biopha.2017.11.127_bib0415","first-page":"1","article-title":"Vesicular carriers for topical delivery","volume":"9","author":"Meidan","year":"1998","journal-title":"Acta Technol. Legis. Med."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.127_bib0420","first-page":"448","article-title":"Ethosomes: a potential carriers for transdermal drug delivery","volume":"2","author":"Rk","year":"2010","journal-title":"Int. J. Drug Dev. Res."},{"issue":"5","key":"10.1016\/j.biopha.2017.11.127_bib0425","first-page":"368","article-title":"Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases","volume":"47","author":"Bhalaria","year":"2009","journal-title":"Indian J. Exp. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.127_bib0430","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1517\/17425247.3.6.727","article-title":"Transfersomes for transdermal drug delivery","volume":"3","author":"Benson","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.127_bib0435","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/2231-4040.97286","article-title":"Effect of permeation enhancers on the penetration mechanism of transfersomal gel of ketoconazole","volume":"3","author":"Rajan","year":"2012","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.biopha.2017.11.127_bib0440","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.colsurfb.2011.12.004","article-title":"A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in-vitro\/in-vivo evaluation","volume":"92","author":"Song","year":"2012","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0445","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: a modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"issue":"84","key":"10.1016\/j.biopha.2017.11.127_bib0450","doi-asserted-by":"crossref","first-page":"68743","DOI":"10.1039\/C5RA10642G","article-title":"Solid lipid nanoparticles of stearic acid for the drug delivery of paliperidone","volume":"5","author":"Kumar","year":"2015","journal-title":"RSC Adv."},{"issue":"33","key":"10.1016\/j.biopha.2017.11.127_bib0455","doi-asserted-by":"crossref","first-page":"26061","DOI":"10.1039\/C4RA16434B","article-title":"Physicochemical studies on local anaesthetic loaded second generation nanolipid carriers","volume":"5","author":"Nahak","year":"2015","journal-title":"RSC Adv."},{"issue":"8","key":"10.1016\/j.biopha.2017.11.127_bib0460","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1211\/jpp.59.8.0002","article-title":"Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in\u2010vitro characterization, ex\u2010vivo and in\u2010vivo studies","volume":"59","author":"Sanna","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"issue":"March (1)","key":"10.1016\/j.biopha.2017.11.127_bib0465","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1208\/s12249-009-9199-0","article-title":"Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery","volume":"10","author":"Bhalekar","year":"2009","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.biopha.2017.11.127_bib0470","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/02652040500162436","article-title":"SLN and NLC for topical delivery of ketoconazole","volume":"22","author":"Souto","year":"2005","journal-title":"J. Microencapsul."},{"issue":"5","key":"10.1016\/j.biopha.2017.11.127_bib0475","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1734-1140(12)70901-5","article-title":"Nanoparticles as drug delivery systems","volume":"64","author":"Wilczewska","year":"2012","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0480","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijpharm.2010.05.020","article-title":"Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles","volume":"395","author":"Mainardes","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.127_bib0485","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.msec.2008.08.012","article-title":"Atomic force microscopy imaging of polyurethane nanoparticles onto different solid substrates","volume":"29","author":"Fritzen-Garcia","year":"2009","journal-title":"Mater. Sci. Eng. C"},{"issue":"7","key":"10.1016\/j.biopha.2017.11.127_bib0490","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.progpolymsci.2011.01.001","article-title":"Polymer nanoparticles: preparation techniques and size-control parameters","volume":"36","author":"Rao","year":"2011","journal-title":"Prog. Polym. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0495","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.nano.2012.04.005","article-title":"Poly-lactide-co-glycolide nanoparticles containing voriconazole for pulmonary delivery: in-vitro and in-vivo study","volume":"9","author":"Sinha","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0500","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3109\/03639045.2012.666978","article-title":"Chitosan based mucoadhesive nanoparticles of ketoconazole for bioavailability enhancement: formulation, optimization, in-vitro and ex-vivo evaluation","volume":"39","author":"Modi","year":"2013","journal-title":"Drug. Dev. Ind. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.127_bib0505","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jconrel.2010.03.016","article-title":"Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting","volume":"145","author":"Li","year":"2010","journal-title":"J. Control. Release"},{"issue":"July (3)","key":"10.1016\/j.biopha.2017.11.127_bib0510","first-page":"290","article-title":"Stealth amphotericin B nanoparticles for oral drug delivery: in vitro optimization","volume":"23","author":"BT","year":"2015","journal-title":"Saudi Pharm. J."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.127_bib0515","first-page":"295","article-title":"Nanocrystal technology, drug delivery and clinical applications","volume":"3","author":"Junghanns","year":"2008","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2017.11.127_bib0520","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2014.02.016","article-title":"Nanocrystal-based per-oral itraconazole delivery: superior in-vitro dissolution enhancement versus Sporanox\u00ae is not realized in in-vivo drug absorption","volume":"180","author":"Sarnes","year":"2014","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0525","first-page":"1184","article-title":"Microsphere: a review","volume":"1","author":"Sahil","year":"2011","journal-title":"Int. J. Res. Pharm. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0530","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ejps.2008.12.009","article-title":"Polymer\u2013lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate","volume":"36","author":"Albertini","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0535","first-page":"39","article-title":"Microemulsions: current trends in novel drug delivery systems","volume":"1","author":"Singh","year":"2014","journal-title":"J. Pharm. Chem. Biol. Sci."},{"issue":"April (1)","key":"10.1016\/j.biopha.2017.11.127_bib0540","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijpharm.2012.01.019","article-title":"Preparation of high solubilizable microemulsion of naproxen and its solubilization mechanism","volume":"426","author":"Tian","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2017.11.127_bib0545","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1080\/01932691.2012.752713","article-title":"Poloxamer-stabilized topical miconazole nitrate-loaded microemulsion: formulation design and characterization","volume":"34","author":"Ofokansi","year":"2013","journal-title":"J. Dispers. Sci. Technol."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0550","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijpharm.2008.08.021","article-title":"Microemulsion based vaginal gel of fluconazole: formulation, in-vitro and in-vivo evaluation","volume":"365","author":"Bachhav","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.127_bib0555","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/0250-474X.56015","article-title":"In situ forming polymeric drug delivery systems","volume":"71","author":"Madan","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0560","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4103\/0250-474X.57291","article-title":"Formulation and evaluation of in situ gels containing clotrimazole for oral candidiasis","volume":"71","author":"Harish","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.127_bib0565","article-title":"A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods","volume":"19","author":"Reddy","year":"2011","journal-title":"Daru"},{"issue":"3","key":"10.1016\/j.biopha.2017.11.127_bib0570","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1208\/s12249-008-9119-8","article-title":"Studies on formulation development of mucoadhesive sustained release itraconazole tablet using response surface methodology","volume":"9","author":"Madgulkar","year":"2008","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0575","first-page":"370","article-title":"Transungual drug delivery a pivotal remedy in onychomycosis","volume":"8","author":"Surender","year":"2016","journal-title":"J. Chem. Pharm. Res."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.127_bib0580","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijpharm.2013.08.082","article-title":"Transungual delivery of ketoconazole using novel lacquer formulation","volume":"456","author":"Hafeez","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"April (3)","key":"10.1016\/j.biopha.2017.11.127_bib0585","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/10837450.2014.999783","article-title":"Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment","volume":"21","author":"Reis","year":"2016","journal-title":"Pharm. Dev. Technol."},{"issue":"June (6)","key":"10.1016\/j.biopha.2017.11.127_bib0590","first-page":"2292","article-title":"Preparation and characterization of nystatin-loaded solid lipid nanoparticles for topical delivery","volume":"4","author":"Khalil","year":"2013","journal-title":"Int. J. Pharm. Sci. Res."},{"issue":"January (1)","key":"10.1016\/j.biopha.2017.11.127_bib0595","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1439-0507.2012.02202.x","article-title":"Evaluation of novel nystatin nanoemulsion for skin candidosis infections","volume":"56","author":"Fern\u00e1ndez\u2010Campos","year":"2013","journal-title":"Mycoses"},{"issue":"September (3)","key":"10.1016\/j.biopha.2017.11.127_bib0600","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1208\/pt030322","article-title":"Double-layered mucoadhesive tablets containing nystatin","volume":"3","author":"Llabot","year":"2002","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"10.1016\/j.biopha.2017.11.127_bib0605","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.nano.2017.06.021","article-title":"Amphotericin B releasing topical nanoemulsion for the treatment of candidiasis and aspergillosis","volume":"13","author":"Lilian","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"August (4)","key":"10.1016\/j.biopha.2017.11.127_bib0610","first-page":"354","article-title":"Solid lipid nanoparticles of amphotericin B (AmbiOnp): in-vitro and in-vivo assessment towards safe and effective oral treatment module","volume":"6","author":"Chaudhari","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"issue":"October (10)","key":"10.1016\/j.biopha.2017.11.127_bib0615","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1166\/jnn.2013.7742","article-title":"Interaction between ketoconazole and human serum albumin on epoxy modified magnetic nanoparticles for drug delivery","volume":"13","author":"Maltas","year":"2013","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"June (3)","key":"10.1016\/j.biopha.2017.11.127_bib0620","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3109\/10837451003610845","article-title":"Investigating effect of microemulsion components: in-vitro permeation of ketoconazole","volume":"16","author":"Patel","year":"2011","journal-title":"Pharm. Dev. Technol."},{"issue":"October (4)","key":"10.1016\/j.biopha.2017.11.127_bib0625","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/2230-973X.107002","article-title":"Formulation and evaluation of Ketoconazole niosomal gel drug delivery system","volume":"2","author":"Shirsand","year":"2012","journal-title":"Int. J. Pharm. Investig."},{"issue":"January (1)","key":"10.1016\/j.biopha.2017.11.127_bib0630","first-page":"55","article-title":"Bioadhesive films containing fluconazole for mucocutaneous candidiasis","volume":"77","author":"Patel","year":"2015","journal-title":"Indian J. Pharm. Sci."},{"issue":"January (2)","key":"10.1016\/j.biopha.2017.11.127_bib0635","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/02652040310001637811","article-title":"Fluconazole encapsulation in PLGA microspheres by spray-drying","volume":"21","author":"Rivera","year":"2004","journal-title":"J. Microencapsul."},{"issue":"December (6)","key":"10.1016\/j.biopha.2017.11.127_bib0640","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3109\/10731199.2011.611476","article-title":"Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery","volume":"39","author":"Gupta","year":"2011","journal-title":"Artif. Cells Blood Substit. Biotechnol."},{"issue":"January (2)","key":"10.1016\/j.biopha.2017.11.127_bib0645","first-page":"433","article-title":"Formulation and evaluation of solid self emulsifying drug delivery sytem of voriconazole","volume":"4","author":"Aparna","year":"2015","journal-title":"World J. Pharm. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.127_bib0650","first-page":"180","article-title":"Formulation and evaluation of voriconazole floating tablets","volume":"5","author":"Parthibarajan","year":"2012","journal-title":"Asian J. Pharm. Clin. Res."},{"issue":"January (1)","key":"10.1016\/j.biopha.2017.11.127_bib0655","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/03639045.2011.590731","article-title":"Microemulsions as vehicles for topical administration of voriconazole: formulation and in-vitro evaluation","volume":"38","author":"El-Hadidy","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"January (1)","key":"10.1016\/j.biopha.2017.11.127_bib0660","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/eri.10.152","article-title":"Miconazole mucoadhesive tablet for oropharyngeal candidiasis","volume":"9","author":"Lalla","year":"2011","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"October (1)","key":"10.1016\/j.biopha.2017.11.127_bib0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(03)00371-5","article-title":"Mucoadhesive buccal patches of miconazole nitrate: in-vitro\/in-vivo performance and effect of ageing","volume":"264","author":"Nafee","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"February (2)","key":"10.1016\/j.biopha.2017.11.127_bib0670","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/10837450.2013.852572","article-title":"Formulation and characterization study of itraconazole-loaded microparticles","volume":"20","author":"Segale","year":"2015","journal-title":"Pharm. Dev. Technol."},{"issue":"November (7)","key":"10.1016\/j.biopha.2017.11.127_bib0675","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/10717544.2013.853212","article-title":"Preparation and evaluation of dual-mode floating gastroretentive tablets containing itraconazole","volume":"21","author":"Kim","year":"2014","journal-title":"Drug Deliv."},{"issue":"October (1)","key":"10.1016\/j.biopha.2017.11.127_bib0680","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijpharm.2012.07.003","article-title":"Preparation and quality assessment of itraconazole transfersomes","volume":"436","author":"Zheng","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"December","key":"10.1016\/j.biopha.2017.11.127_bib0685","article-title":"Itraconazole niosomes drug delivery system and its antimycotic activity against Candida albicans","author":"Wagh","year":"2012","journal-title":"ISRN Pharm."},{"issue":"January (4)","key":"10.1016\/j.biopha.2017.11.127_bib0690","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/02652040500435295","article-title":"Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization","volume":"23","author":"Souto","year":"2006","journal-title":"J. Microencapsul."},{"issue":"February (2)","key":"10.1016\/j.biopha.2017.11.127_bib0695","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1248\/cpb.c13-00689","article-title":"Vaginal chitosan tablets with clotrimazole-design and evaluation of mucoadhesive properties using porcine vaginal mucosa, mucin and gelatine","volume":"62","author":"Szyma\u0144ska","year":"2014","journal-title":"Chem. Pharm. Bull."},{"issue":"January (4-5)","key":"10.1016\/j.biopha.2017.11.127_bib0700","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1081\/DDC-54315","article-title":"Preparation, in-vitro and in-vivo evaluation of liposomal\/niosomal gel delivery systems for clotrimazole","volume":"31","author":"Ning","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0705","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/AAC.01141-06","article-title":"Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals","volume":"51","author":"Choi","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"s7","key":"10.1016\/j.biopha.2017.11.127_bib0710","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non\u2010neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0715","first-page":"175","article-title":"Epidemiology and treatment approaches in management of invasive fungal infections","volume":"3","author":"Kriengkauykiat","year":"2011","journal-title":"Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.127_bib0720","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1592\/phco.27.3.369","article-title":"The echinocandins","volume":"27","author":"Cappelletty","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.biopha.2017.11.127_bib0725","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1439-0507.2008.01645.x","article-title":"Treatment of invasive candidiasis with echinocandins","volume":"52","author":"Gl\u00f6ckner","year":"2009","journal-title":"Mycoses"},{"issue":"15","key":"10.1016\/j.biopha.2017.11.127_bib0730","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1021\/jm00093a018","article-title":"Preparation and structure-activity relationships of simplified analogs of the antifungal agent cilofungin: a total synthesis approach","volume":"35","author":"Zambias","year":"1992","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.127_bib0735","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.mi.48.100194.002351","article-title":"Antibiotics that inhibit fungal cell wall development","volume":"48","author":"Debono","year":"1994","journal-title":"Annu. Rev. Microbiol."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.127_bib0740","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jmicro\/51.4.247","article-title":"Morphological changes of Candida albicans induced by micafungin (FK463), a water\u2010soluble echinocandin\u2010like lipopeptide","volume":"51","author":"Nishiyama","year":"2002","journal-title":"J. Electron. Microsc."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217348941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217348941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:33:57Z","timestamp":1778243637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217348941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":148,"alternative-id":["S0753332217348941"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.11.127","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in delivery of antifungal agents for therapeutic management of candidiasis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.11.127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}